Health Legislation

This Decree approves the amended statutes of the Beninese pharmaceutical regulatory agency, now named “Beninese Agency for Medicines and other Health Products”.

This law, published in the Official Journal on 25 Mai 2023, modifies articles 1,17,27,51 and 79 of the law n°37-2014 establishing the universal health insurance scheme.

This regulation is issued to implement Proclamation No. 1273/2022 Community-Based Health Insurance Proclamation. It establishes the framework for managing health insurance pools and reserve funds (Sections 3-6), outlines membership and contribution procedures (Sections 7-9), and details provider payment mechanisms (Section 10). It also addresses fund management, financial deficit coverage (Sections 11-13), and miscellaneous provisions such as co-payment and data management (Sections 14-20).

This Act establishes the framework for the management of social health insurance; provides for the establishment of the Social Health Authority; gives effect to Article 43(1)(a) of the Constitution; and for connected purposes.

This Act sets conditions to facilitate access to health services for citizens through health insurance, establishes a health insurance system for all, sets conditions for expanding the scope of various health services; and sets other related conditions.

This Act sets conditions to facilitate access to health services for citizens through health insurance, establishes a health insurance system for all, sets conditions for expanding the scope of various health services; and sets other related conditions.

This Proclamation provides the legal framework for the Community Based Health Insurance System.

The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.

These Instructions govern private health facilities.

This Decree establishes and fixes the rules of organization and operation of the Senegalese Pharmaceutical Regulatory Agency (ARP)

The law creates the Burundian Authority for the Regulation of Medicines for Human Use and Food. The authority's general aim is to protect public health by promoting the quality and safety of products such as prefabricated and ambient foods, medicines for human use, cosmetics and dietary products containing active ingredients, herbal medicines, traditional medicines, and medical devices, among others.

The Decree approves the Organic Statute of the Autoridade Nacional Reguladora de Medicamento (The National Medicines Regulatory Authority). The purpose of this Decree is to define the rules governing the organization, management and operation, as well as the powers of its bodies.

The instructions govern dual clinical practice in Rwanda. The Instructions apply to medical doctors and dental surgeons working in health facilities.

The Instructions are intended to improve the quality of health care services provided in private health facilities to the Rwandan population and to determine the basic requirements for the operation of a private health facility. These instructions do not regulate traditional, alternative and complementary medicine.

This Law amends the Law 03/2015 of 02/03/2015 governing the Organisation of Community-Based Health Insurance Scheme. Please refer to page 171 of the file to see the text of the Law.

This Act establishes the Pharmacy and Medicines Regulatory Authority; provides for the functions and powers of the Authority; and provides for matters connected therewith and incidental thereto.

The document establishes the standards for the authorization to operate a private health facility in Rwanda.

The law creates a compulsory health insurance scheme known as the "Régime d'Assurance Maladie Universelle" (Universal Health Insurance Scheme) designed to cover the health care costs attached to sickness and maternity for insured persons and their dependent family members.

This Law amends the Law 03/2015 of 02/03/2015 governing the Organisation of Community-Based Health Insurance Scheme.

The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).